Phase 3 Alcohol Use Disorder Clinical Trials
9 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–9 of 9 trials
Recruiting
Phase 2Phase 3
Alcohol Use Disorder and Cannabidiol
Alcohol Use Disorder
University of Colorado, Denver180 enrolled1 locationNCT05613608
Recruiting
Phase 3
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Eli Lilly and Company1,100 enrolled123 locationsNCT07219966
Recruiting
Phase 3
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Eli Lilly and Company1,100 enrolled119 locationsNCT07219953
Recruiting
Phase 2Phase 3
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
Post Traumatic Stress DisorderAlcohol Use Disorder
VA Office of Research and Development80 enrolled2 locationsNCT07118839
Recruiting
Phase 2Phase 3
Ketone Ester Intervention in Alcohol Use Disorder
Alcohol DrinkingAlcohol Use Disorder
University of Pennsylvania20 enrolled1 locationNCT04616781
Recruiting
Phase 2Phase 3
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
alcohol withdrawalKetosisAlcohol Use Disorder
University of Pennsylvania30 enrolled1 locationNCT06559995
Recruiting
Phase 3
Electronic Harm Reduction Treatment for Alcohol
Alcohol Use DisorderHarm ReductionHousing First (eg. Permanent Supportive Housing)
University of Washington160 enrolled1 locationNCT06702007
Recruiting
Phase 3
Emergency Department-Initiated Medications for Alcohol Use Disorder
Alcohol Use Disorder
Yale University240 enrolled1 locationNCT05827159
Not Yet Recruiting
Phase 3Phase 4
A pilot investigation of the effects of Baclofen on a quantitative electroencephalographic predictor of relapse to alcohol dependence.
Alcohol Use Disorder
Royal Adelaide Hospital20 enrolled1 locationACTRN12613000372785